How to contact MHRA for specific services or enquiries.
Medicines Healthcare Products Regulatory Agency
- Guidance: Hold a bird gathering
- Guidance: Notice to Traders 35/24 - Milk Products Import Quota
- Guidance: Air strikes against Houthi military targets in Yemen
- Guidance: Sentencing guidance for the Service Courts
- Press release: Royal Navy ship joins international effort to build pier for aid delivery into Gaza by sea
- Guidance: Contact MHRA
- Guidance: United Kingdom Single Issuing Authority (UKSIA)
- Correspondence: Circular 004/2024: cryptoasset confiscation order provisions
- Correspondence: Circular 005/2024: cryptoasset forfeiture provisions
- Transparency data: Upper Tribunal Administrative Appeals Chamber cause list
List of manufacturers and their medical devices which have been granted an exemption by the MHRA. The list also includes manufacturers whose exemption expired or was cancelled. This information will be listed for 2 months after expiry or cancellation.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
List of Field Safety Notices from15 to 19 April 2024.
A list of authorised orphan medicinal products registered by the UK Licensing Authority.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
UK approved bodies listed under?Medical Devices Regulations 2002?(SI 2002 No 618, as amended) (UK MDR 2002).
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
The MHRA was alerted by Beyond Compliance and the UK National Joint Registry (NJR) to a significantly higher revision rate observed with the ORIGIN PS patient-matched total knee replacement.
Marketing authorisations granted in 2024
Parallel import licences granted in 2024
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
An overview of the process including submitting or fast tracking an application, naming your medicine and paying fees.
Information about suspected side effects of e-cigarettes and how to report side effects.
Marketing Authorisation Holders should review their manufacturing processes to identify and, if found, to mitigate the risk of nitrosamine impurities being present.
A list of authorised CAP Bridging Mechanism products registered by the UK Licensing Authority.
List of manufacturers and their medical devices which have been granted an exemption by the MHRA. The list also includes manufacturers whose exemption expired or was cancelled. This information will be listed for 2 months after expiry or cancellation.
List of manufacturers and their medical devices which have been granted an exemption by the MHRA. The list also includes manufacturers whose exemption expired or was cancelled. This information will be listed for 2 months after expiry or cancellation.
Information for healthcare professionals and the public on Moderna's bivalent vaccines. Information on the original Spikevax COVID-19 vaccine can found on a separate page (link below)
Information for healthcare professionals and the public about the adapted Spikevax XBB.1.5 vaccine
Use the rolling review route when you want to submit your eCTD dossier in separate parts for pre-assessment instead of making a full consolidated document submission.
Guidance on the 150-day assessment timeline for high-quality marketing authorisation applications including information on how to apply.
Marketing authorisations granted in 2024
Parallel import licences granted in 2024
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Transparency data: MHRA performance data for assessment of clinical trials and established medicines
MHRA performance metrics for clinical trials and established medicines assessment.
The Medicines and Healthcare Regulatory Agency have launched RegulatoryConnect, a service that provides the capability to track applications and view live authorisation details.
List of Field Safety Notices from 8 to 12 April 2024.
The MHRA register of licensed manufacturing sites - manufacturer specials (human) (MS) and manufacturer specials authorisation (veterinary) (MANSA) only.
Current listing of UK brokers authorised to broker human medicines, including company name, registration and address.
List of sites granted a manufacturer or wholesale dealer licence
UK companies who have their licence to manufacture or wholesale medicines terminated and cancelled.
Department of Health and Social Care and MHRA register of licensed wholesale distribution sites (human and veterinary).
Information on Medicines and Healthcare products Regulatory Agency spending over £25,000.
Public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended.
List of Field Safety Notices from 2 to 6 October 2023.
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
Public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Accord-UK Ltd is recalling a specific batch of Co-Codamol 8/500mg Effervescent Tablets (Key Pharmaceuticals Livery) as a precautionary measure due to the internal tablet blister strips being printed with an incorrect expiry date.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Performance data relating to the handling of Freedom of Information requests to the Medicines and Healthcare Regulatory Agency (MHRA).
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 April 2024) approved the medicine fosdenopterin (Nulibry) to treat the genetic disease Molybdenum Cofactor Deficiency (MoCD) Type A
A list of authorised orphan medicinal products registered by the UK Licensing Authority.
Ministerial Departmental News
- PM's Office, 10 Downing Street
- Cabinet Office
- Department for Business, Innovation and Skills
- Department for Communities and Local Government
- Department for Culture, Media and Sport
- Department for Education
- Department for Environment, Food and Rural Affairs
- Department for International Development
- Department for Transport
- Department for Work and Pensions
- Department of Energy and Climate Change
- Department of Health
- Foreign and Commonwealth Office
- HM Treasury
- Home Office
- Ministry of Defence
- Ministry of Justice
- Northern Ireland Office
- Scotland Office
- Wales Office
- See all departments